Relationship Between Blood Glucose Variability and Prognosis in Critically Ill Patients
NCT ID: NCT03629704
Last Updated: 2018-08-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
200 participants
OBSERVATIONAL
2018-08-03
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Relationship Between Blood Glucose Levels and Variability and Infections Development in Critically Ill Patient
NCT02659995
Accuracy, Feasibility and Acceptance of Continuous Glucose Monitoring in Critically Ill Patients
NCT02296372
Continuous Glucose Monitoring in Inpatients
NCT06329297
Identification of Inpatients at Risk for Poor Glycemic Control
NCT01043042
Evaluation of Continuous Glucose Monitoring in Patients With ACS and Type 2 Diabetes in ICU
NCT04822740
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Continuous Glucose Monitoring System
Continuous Glucose Monitoring System for 72 hours
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients without history of diabetes, but their random blood glucoseā§7.8mmol/L or fast blood glucoseā§5 mmol/L;
3. The patients hospitalized in care unit (ICU or CCU) for more than 48 hours.
Exclusion Criteria
2. Patient was not suitable for using the CGMS;
3. blood glucose \> 22.2 mmol/L at admission.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nanjing First Hospital, Nanjing Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jianhua Ma, MD
Role: PRINCIPAL_INVESTIGATOR
The First Affiliated Hospital with Nanjing Medical University
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KY20170904-06
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.